Date | Time | Source | Headline | Symbol | Company |
09/15/2024 | 4:42AM | PR Newswire (US) | Luohu Explores Economic Opportunities in Europe, Strengthens Ties with Portugal | | |
09/15/2024 | 4:30AM | PR Newswire (US) | Hispanic Heritage month: The Children's Museum of Indianapolis Unveils Take Me There®: Peru and Launches Latino Community Initiative to Deepen Cultural Connections | | |
09/15/2024 | 4:30AM | PR Newswire (US) | Monster Energy's Kokomo Murase Claims First Place in Women's Snowboard Slopestyle at Winter Games NZ FIS Snowboard Slopestyle World Cup in New Zealand | | |
09/15/2024 | 4:27AM | Alliance News | UK manufacturers believe change in government will boost growth | | |
09/15/2024 | 4:26AM | Alliance News | China says has sovereignty over reef after Philippine ship leaves | | |
09/15/2024 | 4:26AM | Alliance News | Biden to use rest of term putting Ukraine in "best position" - advisor | | |
09/15/2024 | 4:06AM | PR Newswire (US) | Sepsis Awareness Reaches 69%, While Misconceptions About Sepsis and Infections Exist | | |
09/15/2024 | 3:38AM | Business Wire | SCF acquisisce Newpark Fluids Systems | NYSE:NR | Newpark Resources Inc |
09/15/2024 | 3:11AM | PR Newswire (US) | Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024 | | |
09/15/2024 | 3:10AM | PR Newswire (US) | Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024 | | |
09/15/2024 | 3:00AM | GlobeNewswire Inc. | 23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study | NASDAQ:ME | 23andMe Holding Company |
09/15/2024 | 3:00AM | GlobeNewswire Inc. | 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial | NASDAQ:ME | 23andMe Holding Company |
09/15/2024 | 3:00AM | GlobeNewswire Inc. | MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024 | NASDAQ:MGNX | MacroGenics Inc |
09/15/2024 | 2:30AM | PR Newswire (US) | New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer | NYSE:JNJ | Johnson and Johnson |
09/15/2024 | 1:34AM | Business Wire | Incyte’s CDK2 Inhibitor INCB123667 zeigt vielversprechende Anzeichen von klinischer Wirkung bei Patienten mit soliden Tumoren in fortgeschrittenem Stadium | NASDAQ:INCY | Incyte Corporation |
09/15/2024 | 1:34AM | Business Wire | INCB123667, l'inhibiteur de la CDK2 d'Incyte, montre des signes prometteurs d'activité clinique chez des patientes atteintes de tumeurs solides avancées, notamment le cancer de l'ovaire | NASDAQ:INCY | Incyte Corporation |
09/15/2024 | 1:30AM | Business Wire | Doğuş Technology and Doğuş Construction Participate in ConteQ Expo 2024 with Innovative Projects | | |
09/15/2024 | 12:48AM | Business Wire | Le rétifanlimab (Zynyz®) d’Incyte prolonge la survie sans progression chez les patients atteints de carcinome épidermoïde du canal anal (SCAC) ; des données ont été présentées lors du Symposium présidentiel de l’ESMO 2024 | NASDAQ:INCY | Incyte Corporation |
09/15/2024 | 12:30AM | PR Newswire (Canada) | Air Canada et l'ALPA concluent un accord préliminaire sur une nouvelle convention de quatre ans | TSX:AC | Air Canada |
09/15/2024 | 12:25AM | PR Newswire (Canada) | Air Canada and ALPA Reach Tentative Agreement on a New Four-Year Contract | TSX:AC | Air Canada |
09/14/2024 | 11:59PM | Business Wire | Dongfeng avvia una nuova iniziativa in Europa, vari nuovi prodotti introdotti offrono opzioni diversificate di mobilità | | |
09/14/2024 | 11:55PM | PR Newswire (US) | At Congressional Black Caucus Foundation's Phoenix Awards, President Biden And Vice President Harris Urge Caucus To Advance Their Vision For The Future Ahead Of The Presidential Election. | | |
09/14/2024 | 10:00PM | PR Newswire (Canada) | JOSH ROSS WINS BIG AT THE 2024 CCMA AWARDS PRESENTED BY TD | | |
09/14/2024 | 9:45PM | GlobeNewswire Inc. | MAX Power Mining Corp. Announces Results of Annual General and Special Meeting | 89N.F | |
09/14/2024 | 9:45PM | PR Newswire (US) | Neil Empson, Pioneer of Fine Italian Wine in the US market, Dies at 85; March 16, 1939 - September 14, 2024 | | |
09/14/2024 | 9:15PM | PR Newswire (Canada) | Avis aux médias - Agenda public du premier ministre du Québec - 15 septembre 2024 | | |
09/14/2024 | 8:52PM | PR Newswire (US) | CNOOC Limited Successfully Withstands Super Typhoon "Yagi" | | |
09/14/2024 | 7:52PM | PR Newswire (US) | SHAPE and I-ELCAP Announce 1st Conference on Integrating Heart and Lung Screening Using Low-Dose CT to be Held September 19-21, 2024 at the New York Academy of Medicine | | |
09/14/2024 | 6:53PM | PR Newswire (US) | Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together | | |
09/14/2024 | 6:00PM | GlobeNewswire Inc. | Momcozy launches Brand Day Campaign and New Initiatives, Empowering Moms Through Cozy Evolution | | |